Acrivon Therapeutics Inc (ACRV) USD0.001

Sell:$1.77Buy:$1.84Price decreased$0.04 (2.23%)

Market closed |
Prices delayed by at least 15 minutes
Sell:$1.77
Buy:$1.84
Change:Price decreased$0.04 (2.23%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$1.77
Buy:$1.84
Change:Price decreased$0.04 (2.23%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
14 May 2026
Peter Blume-JensenChairman/CEO
Sell
Tax related
1,253$1.92$2,405.762,078,951
14 May 2026
Peter Blume-JensenChairman/CEO
Sell
Tax related
490$1.92$940.80313,637
14 May 2026
Eric J DevroeCOO
Sell
Tax related
613$1.92$1,176.9673,972
14 May 2026
Mary-Alice MillerChief Legal/Compliance Officer
Sell
Tax related
184$1.92$353.2832,937
14 May 2026
Erick GamelinChief Level Officer
Sell
Tax related
404$1.92$775.6814,408
14 May 2026
Katharine (Katie) PetersonChief Accounting Officer
Sell
Tax related
99$1.92$190.083,907
22 April 2026
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
3,888,888$1.80$6,999,998.4011,803,094
17 April 2026
Mary-Alice MillerChief Legal/Compliance Officer
Sell
Tax related
558$1.78$993.2433,121
21 February 2026
Peter Blume-JensenChairman/CEO
Sell
Tax related
14,265$1.53$21,825.452,080,204
14 February 2026
Peter Blume-JensenChairman/CEO
Sell
Tax related
1,302$1.63$2,122.262,094,469

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
22 April 2026
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
3,888,888$1.80$6,999,998.4011,803,094
14 November 2025
Peter Blume-JensenChairman/CEO
Sell
Tax related
59,765$2.24$133,873.602,066,675
14 August 2025
Peter Blume-JensenChairman/CEO
Sell
Tax related
59,766$1.39$83,074.742,146,345
14 January 2026
Peter Blume-JensenChairman/CEO
Buy
Regular purchase transaction
49,000$1.68$82,124.002,095,771
21 November 2025
Peter Blume-JensenChairman/CEO
Sell
Tax related
19,904$2.30$45,779.202,046,771

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.